CLOUDBREAK
Live / Registered — Registered (as of 27 Jan 2026)
What this means for you
Registered since 27 Jan 2026. The owner can stop confusingly similar uses in the classes it covers; it stays on the register as long as the owner keeps up the maintenance filings (next due by 27 Jan 2032: the §8 declaration of use).
Record
- Serial number
- 98528993
- Registration number
- 8120186
- Mark type
- Word mark
- Filed
- 01 May 2024
- Published for opposition
- 11 Feb 2025
- Registered
- 27 Jan 2026
- Next maintenance filing
- §8 declaration of use, due by 27 Jan 2032 (grace period to 27 Jul 2032)
- Attorney of record
- Allison Strickland Ricketts
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for the prevention and treatment of infectious diseases and disorders, autoimmune diseases and disorders, and cancer for human use
Owner
- Cidara Therapeutics, Inc., San Diego, CA
- Cidara Therapeutics, Inc., San Diego, CA
- Cidara Therapeutics, Inc., San Diego, CA
Prosecution history
- 27 Jan 2026 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 27 Jan 2026 — REGISTERED-PRINCIPAL REGISTER
- 06 Jan 2026 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 06 Jan 2026 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 29 Nov 2025 — STATEMENT OF USE PROCESSING COMPLETE
- 06 Jun 2025 — USE AMENDMENT FILED
- 29 Nov 2025 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 06 Jun 2025 — TEAS STATEMENT OF USE RECEIVED
- 08 Apr 2025 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 11 Feb 2025 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 11 Feb 2025 — PUBLISHED FOR OPPOSITION
- 05 Feb 2025 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 21 Jan 2025 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 06 Jan 2025 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 06 Jan 2025 — CORRESPONDENCE RECEIVED IN LAW OFFICE